Search Results for: ZYX

36 interactions involving ZYX - zyxin found:

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
ACTN1 actinin alpha 1
  • Platelet degranulation
  • Syndecan interactions
  • Nephrin family interactions
  • Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
  • RHOD GTPase cycle
  • RHOBTB2 GTPase cycle
  • RHOF GTPase cycle
  • Human calcitonin
  • Copper
ATXN1 ataxin 1
  • Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
BSPRY B-box and SPRY domain containing
CASS4 Cas scaffold protein family member 4
CEBPA CCAAT enhancer binding protein alpha
  • Transcriptional regulation of white adipocyte differentiation
  • Transcriptional regulation of white adipocyte differentiation
  • Transcriptional regulation of granulopoiesis
  • Transcriptional regulation of granulopoiesis
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • Acute myeloid leukemia (AML)
ENAH ENAH actin regulator
  • Generation of second messenger molecules
  • Signaling by ROBO receptors
  • Signaling by ROBO receptors
EVL Enah/Vasp-like
  • Generation of second messenger molecules
  • Signaling by ROBO receptors
  • Signaling by ROBO receptors
  • RHO GTPases Activate Formins
HIPK3 homeodomain interacting protein kinase 3
  • Fostamatinib
IMP3 IMP U3 small nucleolar ribonucleoprotein 3
  • rRNA modification in the nucleus and cytosol
  • Major pathway of rRNA processing in the nucleolus and cytosol
LAP3 leucine aminopeptidase 3
  • Leucine Phosphonic Acid
  • (2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid
  • Zofenoprilat
LASP1 LIM and SH3 protein 1
LATS1 large tumor suppressor kinase 1
  • Signaling by Hippo
  • Fostamatinib
LIN7A lin-7 cell polarity scaffold A
  • Dopamine Neurotransmitter Release Cycle
  • Neurexins and neuroligins
  • Assembly and cell surface presentation of NMDA receptors
NEBL nebulette
NEDD9 neural precursor cell expressed, developmentally down-regulated 9
NME5 NME/NM23 family member 5
OPRM1 opioid receptor mu 1
  • Opioid Signalling
  • G-protein activation
  • Peptide ligand-binding receptors
  • G alpha (i) signalling events
  • Interleukin-4 and Interleukin-13 signaling
  • MECP2 regulates neuronal receptors and channels
  • Tramadol
  • Morphine
  • Codeine
  • Amitriptyline
  • Hydromorphone
  • Methadone
  • Meperidine
  • Oxycodone
  • Levallorphan
  • Dextromethorphan
  • Butorphanol
  • Dextropropoxyphene
  • Pentazocine
  • Naltrexone
  • Sufentanil
  • Alfentanil
  • Fentanyl
  • Loperamide
  • Nalbuphine
  • Levorphanol
  • Remifentanil
  • Ondansetron
  • Anileridine
  • Buprenorphine
  • Hydrocodone
  • Diphenoxylate
  • Naloxone
  • Oxymorphone
  • Dezocine
  • Ketamine
  • Levacetylmethadol
  • Aripiprazole
  • Methadyl acetate
  • 3-Methylthiofentanyl
  • Dimethylthiambutene
  • Diamorphine
  • Ethylmorphine
  • Etorphine
  • Carfentanil
  • Diprenorphine
  • Dihydromorphine
  • 3-Methylfentanyl
  • V1003
  • Epicept NP-1
  • LI-301
  • Tapentadol
  • Nalmefene
  • Alvimopan
  • Amisulpride
  • Morphine glucuronide
  • Ketobemidone
  • Methylnaltrexone
  • Naloxegol
  • Cannabidiol
  • Trimebutine
  • Butyrfentanyl
  • Pholcodine
  • Eluxadoline
  • Tianeptine
  • Opium
  • Pentoxyverine
  • Naldemedine
  • Samidorphan
  • Metenkefalin
  • Medical Cannabis
  • Nabiximols
  • Loxicodegol
  • Oliceridine
PDLIM5 PDZ and LIM domain 5
  • Neurexins and neuroligins
PHF21A PHD finger protein 21A
  • HDACs deacetylate histones
  • Potential therapeutics for SARS
  • Factors involved in megakaryocyte development and platelet production
QRICH1 glutamine rich 1

Page 1 out of 2 pages